Search results for "Lymph"

showing 10 items of 4590 documents

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

2016

Melanoma treatment has been revolutionized by antibody-based immunotherapies. IFNγ secretion by CD8+ T cells is critical for therapy efficacy having anti-proliferative and pro-apoptotic effects on tumour cells. Our study demonstrates a genetic evolution of IFNγ resistance in different melanoma patient models. Chromosomal alterations and subsequent inactivating mutations in genes of the IFNγ signalling cascade, most often JAK1 or JAK2, protect melanoma cells from anti-tumour IFNγ activity. JAK1/2 mutants further evolve into T-cell-resistant HLA class I-negative lesions with genes involved in antigen presentation silenced and no longer inducible by IFNγ. Allelic JAK1/2 losses predisposing to …

Patient-Specific Modeling0301 basic medicineSkin NeoplasmsBiopsyT-LymphocytesDNA Mutational AnalysisDatasets as TopicGeneral Physics and AstronomyAntineoplastic Agents ImmunologicalMutation RatePrecision MedicineMelanomaSkinAntigen PresentationMultidisciplinarybiologyMelanomaQfood and beverages3. Good healthTreatment Outcomemedicine.anatomical_structureImmunotherapyAntibodySignal TransductionScienceT cellAntigen presentationHuman leukocyte antigenArticleGeneral Biochemistry Genetics and Molecular BiologyInterferon-gamma03 medical and health sciencesAntigenAntigens NeoplasmCell Line TumormedicineHumansWhole Genome SequencingHistocompatibility Antigens Class IJanus Kinase 1General ChemistryJanus Kinase 2medicine.disease030104 developmental biologyImmunoeditingDrug Resistance NeoplasmMutationImmunologybiology.proteinTumor EscapeCD8Nature Communications
researchProduct

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in hum…

1986

The present study performed on a total of 567 cases of human female breast cancer compares the results of the biochemical assay (dextran-coated charcoal assay = DCC) for oestrogen receptor (ER) with those of several morphological methods developed for the detection of the ER or for the prediction of prognosis by use of other systems (FSA = fluorescent ligand binding assay, ER-ICA = monoclonal antibody assay for ER, LRA = lectin receptor assay using peanut agglutinin, and Barr body estimation). Whereas no correlation at all was observed among the results of the DCC and those of the FSA and Barr body estimation, the ER-ICA and the LRA showed an unanimous tendency towards higher values of ER w…

Peanut agglutininPathologymedicine.medical_specialtymedicine.drug_classBreast NeoplasmsMonoclonal antibodyPathology and Forensic MedicinePeanut AgglutininLectinsmedicineHumansLymphocytesReceptorMolecular BiologyFluorescent DyesImmunoassaybiologyHistocytochemistryLigand binding assayAssayCancerAntibodies MonoclonalDextransCell BiologyGeneral Medicinemedicine.diseaseFluoresceinsMolecular biologyReceptors EstrogenSex ChromatinCharcoalReceptors MitogenMonoclonalbiology.proteinImmunohistochemistryFemaleFluorescein-5-isothiocyanateThiocyanatesVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

2021

AbstractAim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortalit…

Pediatricsmedicine.medical_specialty2019-20 coronavirus outbreakAspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki diseaseReview030204 cardiovascular system & hematologyMucocutaneous Lymph Node SyndromeDiagnosis Differential03 medical and health sciences0302 clinical medicine030225 pediatricshemic and lymphatic diseasesmedicineHumansChildCoronary artery abnormalitieChildrenIntravenous immunoglobulinAspirinAspirinKawasaki diseasebusiness.industryClinical courselcsh:RJ1-570Immunoglobulins Intravenouslcsh:PediatricsGeneral MedicineDelayed treatmentmedicine.diseasePrognosisSettore MED/38Disease phasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAEl NiñoItalyTreatment modalityDisease ProgressionAspirin Children Coronary artery abnormalities Intravenous immunoglobulin Kawasaki diseaseKawasaki diseasebusinessCoronary artery abnormalitiesmedicine.drug
researchProduct

Patient with Kabuki syndrome and acute leukemia

2003

Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome which often involves recurrent infections. There is cumulative evidence of an immunodeficiency in Kabuki patients. We report a 2-year-old girl with typical Kabuki syndrome, who developed acute lymphocytic leukemia. The patient showed low levels of immunoglobulins G and A and a history of recurrent infections, that might indicate an immunodeficiency leading to an increased susceptibility to cancer. The girl was treated according to BFM protocols adapted to the patient's impaired cardiac situation and severe underweight. She achieved continual complete remission. Classical and molecular cytogenetic analyzes did not d…

Pediatricsmedicine.medical_specialtyAcute leukemiabusiness.industryKabukiInfantCancerPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseIntellectual DisabilityImmunopathologyAcute lymphocytic leukemiaImmunologymedicineHumansAbnormalities MultipleFemaleAbnormalitybusinessKabuki syndromeGenetics (clinical)ImmunodeficiencyAmerican Journal of Medical Genetics
researchProduct

Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report

2021

Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia (platelet count <100 × 109/l) in the absence of other causes or disorders associated. The incidence of ITP in pregnancy is one to two cases per 1000 gestations. ITP could be diagnosed before or during pregnancy; sometimes a relapse of a previously diagnosed ITP can occur. Intravenous immune globulins (IVIg) and corticosteroids are the standard frontline therapy because of their well known safety profile either for the mother or for the neonate. Treatments for refractory patients are limited by potential fetal risk. We report the case of a patient with ITP along pregnancy, refractory…

Pediatricsmedicine.medical_specialtyAdolescenteltrombopag pregnancy.EltrombopagBenzoateschemistry.chemical_compoundRefractoryPregnancyhemic and lymphatic diseasesMedicineHumansThrombopoietin receptorFetusPregnancyPurpura Thrombocytopenic Idiopathicbusiness.industryPlatelet CountIncidence (epidemiology)Pregnancy Complications HematologicInfant NewbornHematologyGeneral Medicinemedicine.diseaseHydrazineschemistryGestationPyrazolesFemalebusinessComplicationReceptors ThrombopoietinPrimary immune thrombocytopenia
researchProduct

756 The Effectiveness of RDW-CV in Differentiating Microcytic Anemia

2012

Backround: Iron deficiency anemia (IDA) and thalassemia are the most common microcytic anemia in children. Sometimes, expensive or invasive investigations are necessary for their distinction. Red cell distribution - coefficient variation (RDW-CV) is a new generation marker more often used in differentiating IDA from thalassemia. A number of hematological indices are also useful (Mentzer, Shine&Lal, Green&King, Ricerca). Aim To demonstrate the effectiveness RDW - CV in differentiating microcytic anemia. Method Retrospective study conducted on a total of 215 patients with microcytic anemia. Criteria for study group selection: MCV and Hb below the minimum age reference (mild anemia, Hb between…

Pediatricsmedicine.medical_specialtyAnemiabusiness.industryMicrocytic anemiaThalassemiaRed blood cell distribution widthRetrospective cohort studymedicine.diseaseIron-deficiency anemiaHematologic disordershemic and lymphatic diseasesPediatrics Perinatology and Child HealthmedicinebusinessPathologicalArchives of Disease in Childhood
researchProduct

Burkitt’s lymphoma in pregnant woman: Difficult management of a rare case

2020

Highlights • Burkitt’s lymphoma, an aggressive non-Hodgkin lymphoma, is extremely rare during pregnancy. • Lymphoma of the small intestine is often overlooked in the early stages of the disease. • We described a multidisciplinary approach, cesarean section with surgical intestinal exploration.

Pediatricsmedicine.medical_specialtyBurkitt’s lymphomaIntestinal involvementNauseaCase ReportDisease03 medical and health sciences0302 clinical medicineimmune system diseasesPregnancyhemic and lymphatic diseasesmedicineNon-Hodgkin lymphomaPregnancyBurkitt's lymphomabusiness.industryGestational agemedicine.diseaseLymphoma030220 oncology & carcinogenesisVomitingGestation030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBurkitt's lymphomaInternational Journal of Surgery Case Reports
researchProduct

Evans’ Syndrome: From Diagnosis to Treatment

2020

Evans’ syndrome (ES) is defined as the concomitant or sequential association of warm auto-immune haemolytic anaemia (AIHA) with immune thrombocytopenia (ITP), and less frequently autoimmune neutropenia. ES is a rare situation that represents up to 7% of AIHA and around 2% of ITP. When AIHA and ITP occurred concomitantly, the diagnosis procedure must rule out differential diagnoses such as thrombotic microangiopathies, anaemia due to bleedings complicating ITP, vitamin deficiencies, myelodysplastic syndromes, paroxysmal nocturnal haemoglobinuria, or specific conditions like HELLP when occurring during pregnancy. As for isolated auto-immune cytopenia (AIC), the determination of the primary or…

Pediatricsmedicine.medical_specialtyEvans syndromemedicine.medical_treatmentSplenectomylcsh:MedicineDiseaseReview03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesMedicineCytopeniabusiness.industryMyelodysplastic syndromeslcsh:RGeneral Medicinemedicine.diseaseEvans’ syndromeimmune thrombocytopenia030220 oncology & carcinogenesisConcomitantAutoimmune neutropeniaRituximabautoimmune haemolytic anaemiabusiness030215 immunologymedicine.drugJournal of Clinical Medicine
researchProduct

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature

2021

Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual…

Pediatricsmedicine.medical_specialtyHeart diseaseSettore MED/17 - Malattie InfettiveDiseaseReviewMucocutaneous Lymph Node SyndromePediatricsRJ1-57003 medical and health sciences0302 clinical medicineRecurrence030225 pediatricsSars-Cov2EpidemiologymedicineHumans030212 general & internal medicineskin and connective tissue diseasesChildPandemicsbusiness.industrySARS-CoV-2Incidence (epidemiology)IncidenceInfantmedicine.diseaseSars-Cov2Coronary arteriesmedicine.anatomical_structureRecurrent Kawasaki diseaseChild PreschoolKawasaki diseaseKawasaki disease recurrenceVasculitisbusinessCovid-19Medical literature
researchProduct

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature

2021

Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transplantation. The clinical picture differs from lymphomas observed in the general population, with different manifestation, histopathology, higher aggressiveness with involvement of sites beyond the primary lymph node, and poorer outcome. The objective of the study was to present nine cases of PTLD observed in our centre among the kidney transplant recipient population and discuss the results with up-to-date literature. We performed a retrospective single-centre assessment of PTLD incidence in the cohorts of kidney transplant recipients followed by our centre. We found nine cases of PTLD, five m…

Pediatricsmedicine.medical_specialtyImmunologyPopulationkidney transplantationCase ReportlymphomaPost-transplant lymphoproliferative disorderhemic and lymphatic diseasesImmunology and AllergyMedicineeducationKidney transplantationeducation.field_of_studybusiness.industryIncidence (epidemiology)Rmedicine.diseaseLymphomaTransplantationsurgical procedures operativekidney transplantation.post-transplant lymphoproliferative diseaseMedicinebusinessComplicationRare diseaseCentral European Journal of Immunology
researchProduct